Nanoparticulate corticosteroid and antihistamine formulations

Details for Australian Patent Application No. 2006226887 (hide)

Owner Elan Pharma International Limited

Inventors Liversidge, Gary; Jenkins, Scott

Agent Davies Collison Cave

Pub. Number AU-A-2006226887

PCT Pub. Number WO2006/102494

Priority 60/664,359 23.03.05 US

Filing date 23 March 2006

Wipo publication date 28 September 2006

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/00 (2006.01)

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102494 Priority application(s): WO2006/102494

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226891-Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy

2006226886-Apparatus and method for monitoring and controlling the transmissibility of mechanical vibration energy during dynamic motion therapy